BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang WJ, Hu CG, Zhu ZM, Luo HL. Effect of P2X7 receptor on tumorigenesis and its pharmacological properties. Biomed Pharmacother 2020;125:109844. [PMID: 32004973 DOI: 10.1016/j.biopha.2020.109844] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Han Y, Bai C, He XM, Ren QL. P2X7 receptor involved in antitumor activity of atractylenolide I in human cervical cancer cells. Purinergic Signal 2022. [PMID: 35235139 DOI: 10.1007/s11302-022-09854-6] [Reference Citation Analysis]
2 Zhu X, Li Q, Song W, Peng X, Zhao R. P2X7 receptor: a critical regulator and potential target for breast cancer. J Mol Med (Berl) 2021;99:349-58. [PMID: 33486566 DOI: 10.1007/s00109-021-02041-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Brenet M, Martínez S, Pérez-Nuñez R, Pérez LA, Contreras P, Díaz J, Avalos AM, Schneider P, Quest AFG, Leyton L. Thy-1 (CD90)-Induced Metastatic Cancer Cell Migration and Invasion Are β3 Integrin-Dependent and Involve a Ca2+/P2X7 Receptor Signaling Axis. Front Cell Dev Biol 2020;8:592442. [PMID: 33511115 DOI: 10.3389/fcell.2020.592442] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Qiao C, Tang Y, Li Q, Zhu X, Peng X, Zhao R. ATP-gated P2X7 receptor as a potential target for prostate cancer. Hum Cell 2022. [PMID: 35657562 DOI: 10.1007/s13577-022-00729-x] [Reference Citation Analysis]
5 Zhao Y, Chen X, He C, Gao G, Chen Z, Du J. Discovery of bilirubin as novel P2X7R antagonist with anti-tumor activity. Bioorg Med Chem Lett 2021;51:128361. [PMID: 34543755 DOI: 10.1016/j.bmcl.2021.128361] [Reference Citation Analysis]
6 Zhang WJ, Hu CG, Luo HL, Zhu ZM. Activation of P2×7 Receptor Promotes the Invasion and Migration of Colon Cancer Cells via the STAT3 Signaling. Front Cell Dev Biol 2020;8:586555. [PMID: 33330466 DOI: 10.3389/fcell.2020.586555] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
7 Zhang W, Luo C, Pu F, Zhu J, Zhu Z. The role and pharmacological characteristics of ATP-gated ionotropic receptor P2X in cancer pain. Pharmacological Research 2020;161:105106. [DOI: 10.1016/j.phrs.2020.105106] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
8 Urwanisch L, Luciano M, Horejs-Hoeck J. The NLRP3 Inflammasome and Its Role in the Pathogenicity of Leukemia. Int J Mol Sci 2021;22:1271. [PMID: 33525345 DOI: 10.3390/ijms22031271] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
9 Ferrari D, Gessi S, Merighi S, Nigro M, Travagli A, Burns JS. Potentiating Cancer Immune Therapy via Nanomaterials and Purinergic Signaling. Front Cell Dev Biol 2022;10:893709. [DOI: 10.3389/fcell.2022.893709] [Reference Citation Analysis]
10 Zhang WJ, Luo C, Huang C, Pu FQ, Zhu JF, Zhu ZM. PI3K/Akt/GSK-3β signal pathway is involved in P2X7 receptor-induced proliferation and EMT of colorectal cancer cells. Eur J Pharmacol 2021;899:174041. [PMID: 33737010 DOI: 10.1016/j.ejphar.2021.174041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Zhang WJ. Effect of P2X purinergic receptors in tumor progression and as a potential target for anti-tumor therapy. Purinergic Signal 2021;17:151-62. [PMID: 33420658 DOI: 10.1007/s11302-020-09761-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Rabelo ILA, Arnaud-Sampaio VF, Adinolfi E, Ulrich H, Lameu C. Cancer Metabostemness and Metabolic Reprogramming via P2X7 Receptor. Cells 2021;10:1782. [PMID: 34359950 DOI: 10.3390/cells10071782] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Ai X, Dong X, Guo Y, Yang P, Hou Y, Bai J, Zhang S, Wang X. Targeting P2 receptors in purinergic signaling: a new strategy of active ingredients in traditional Chinese herbals for diseases treatment. Purinergic Signal 2021;17:229-40. [PMID: 33751327 DOI: 10.1007/s11302-021-09774-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zheng Q. Radioligands targeting purinergic P2X7 receptor. Bioorganic & Medicinal Chemistry Letters 2020;30:127169. [DOI: 10.1016/j.bmcl.2020.127169] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Li Q, Zhu X, Song W, Peng X, Zhao R. The P2X7 purinergic receptor: a potential therapeutic target for lung cancer. J Cancer Res Clin Oncol 2020;146:2731-41. [PMID: 32892231 DOI: 10.1007/s00432-020-03379-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]